{"nct_id":"NCT04752696","title":"Onvansertib in Combination with Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants with Metastatic Pancreatic Ductal Adenocarcinoma","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2021-06-07","start_date_type":"ACTUAL","primary_completion_date":"2024-12-24","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CRDF"]}